0001213900-19-021556.txt : 20191030
0001213900-19-021556.hdr.sgml : 20191030
20191030200231
ACCESSION NUMBER: 0001213900-19-021556
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191030
DATE AS OF CHANGE: 20191030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattes Glenn R.
CENTRAL INDEX KEY: 0001568678
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 191181616
MAIL ADDRESS:
STREET 1: 200 ROUTE 31 NORTH
STREET 2: SUITE 104
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4/A
1
ownership.xml
X0306
4/A
2019-10-25
2019-10-29
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001568678
Mattes Glenn R.
2600 VIA FORTUNA, SUITE 360
AUSTIN
TX
78746
1
1
0
0
President and CEO
Common Stock
2019-10-25
4
P
0
10000
5.00
A
10000
D
Common Stock
2019-10-25
4
P
0
10000
5.00
A
10000
I
By Spouse
Stock Options (Right to Buy)
5.00
2019-10-29
4
A
0
332868
0.00
A
2029-10-29
Common Stock
332868
945891
D
The shares of common stock purchased in the Issuer's initial public offering.
25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
/s/Glenn R. Mattes, by Kirk Allen Coleman, as Attorney-in-Fact
2019-10-30